TG Therapeutics Inc (TGTX) financials · rev $616.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
TG Therapeutics Inc (TGTX) rev $616.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $616.3M | $329.0M |
| Cost of Revenue | $100.7M | $38.5M |
| Gross Profit | $515.6M | $290.5M |
| Operating Income | $123.3M | $41.9M |
| Net Income | $447.2M | $23.4M |
| EPS (Diluted) | $2.77 | $0.15 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.06B | $577.7M |
| Current Assets | $630.8M | $566.4M |
| Cash & Equivalents | $79.1M | $179.9M |
| Inventory | $125.6M | $110.5M |
| Total Liabilities | $415.2M | $355.3M |
| Current Liabilities | $153.8M | $90.7M |
| Long-term Debt | $245.6M | $244.4M |
| Total Debt | $245.6M† | $244.4M† |
| Shareholders' Equity | $648.0M | $222.4M |
| Retained Earnings | -$1.08B | -$1.53B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$24.8M | -$40.5M |
| CapEx | $214.0K | $45.0K |
| Investing Cash Flow | $13.8M | -$1.04M |
| Financing Cash Flow | -$89.7M | $128.5M |
| Net Change in Cash | -$100.7M | $87.0M |
| Free Cash Flow | -$25.0M | -$40.6M |
FAQ
What is TGTX P/E and revenue?
TG Therapeutics Inc (TGTX) rev $616.3M.
What is TGTX revenue?
TG Therapeutics Inc last cached revenue is $616.3M (FY2025).
Is TGTX profitable?
TG Therapeutics Inc last cached net income is $447.2M (FY2025).
What are TGTX total assets?
TG Therapeutics Inc last cached total assets are $1.06B (FY2025).
What is TGTX free cash flow?
TG Therapeutics Inc last cached free cash flow is -$25.0M (FY2025).
Not investment advice. Cached statements, not a live tape.